Omeros

Omeros Liabilities

The The Liabilities of Omeros (OMER) as of Nov 17, 2026 is 446.86 M USD. In the previous year, The Liabilities was 459.69 M USD — a change of -2.79% (lower).

Liabilities

446.86 MUSD

YoY

-2.79%

Last updated:

In 2025, Omeros's total liabilities amounted to 446.86 M USD, a -2.79% difference from the 459.69 M USD total liabilities in the previous year.

The Omeros Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
-4.22 M USD
Jan 1, 2019
245.99 M USD
Jan 1, 2020
301.79 M USD
Jan 1, 2021
395.49 M USD
Jan 1, 2022
505.29 M USD
Jan 1, 2023
403.25 M USD
Jan 1, 2024
459.69 M USD
Jan 1, 2025
446.86 M USD
The Omeros Liabilities history
YEARLiabilitiesYoY
446.86 MUSD-2.79%
459.69 MUSD+14.00%
403.25 MUSD-20.19%
505.29 MUSD+27.76%
395.49 MUSD+31.05%
301.79 MUSD+22.69%
245.99 MUSD-5,929.15%
-4.22 MUSD-103.54%
119.14 MUSD+13.77%
104.73 MUSD+39.21%
75.23 MUSD+39.98%
53.74 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Omeros's Liabilities

Omeros's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Omeros's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Omeros's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Omeros's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Omeros’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Omeros stock

The Liabilities of Omeros is 446.86 M USD in 2025.

The Liabilities of Omeros changed from 459.69 M USD to 446.86 M USD, representing a -2.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Omeros since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Omeros historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Omeros

All Key Metrics — Omeros